Back

Physical activity levels and sedentary behaviour pattern in cardiovascular disease patients attending a community-based phase III CR program

14 April 2023 (15:25 - 16:25)
Organised by:
Congress Presentation Part of: Moderated ePoster 15 Cardiovascular Rehabilitation EAPC Premium Access ESC Preventive Cardiology 2023

About the speaker

Photo
Professor Rita Pinto

Faculty of Medicine of the University of Lisbon, Lisbon (Portugal)

8 More presentations in this session

Presentation thumbnail
Effectiveness of a Sedentary Behaviour Intervention as a Personalised Secondary Prevention Strategy (SIT LESS) for patients with coronary artery disease: primary outcomes of the SIT LESS trial
Mr B. van Bakel (Nijmegen, NL)
Abstract Slides
Presentation thumbnail
Does sedentary and physical activity behaviour change between exercise session days vs non exercise session days in patients attending a phase 3 cardiac rehabilitation program?
Mr G. Cicio Rodrigues De Sa (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Digital health nudging to increase physical activity and quality of life in pediatric patients with congenital heart disease: a randomized controlled trial
Ms L. Willinger (Munich, DE)
Abstract Slides
Presentation thumbnail
One size does not fit all - translating absolute accelerometry to relative individual physical activity intensity for health
Mr J. Fridolfsson (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Physical activity levels and statin therapy: differences between symptomatic and asymptomatic statin users
Mrs N. Allard (Nijmegen, NL)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePoster 15

The Event

Event poster

ESC Preventive Cardiology 2023

14 April 2023 15:25 CET
You may be interested in
thumbnail
Congress Session
How to prescribe exercise for people with valvular heart disease or hypertension
thumbnail
Congress Session
Challenges in sports eligibility: what to do with…
thumbnail
Congress Presentation
A multicomponent cardiac rehabilitation program as a safe, feasible and beneficial approach, also for patients with a left ventricular assist device

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources